Safety Incidents OSHA Severe Injury Reports · 2015–2025
5,197,124Inspections Most recent open 2026-08-25 Last loaded 2026-08-28

OSHA Inspection: RARITAN PHARMACEUTICALS

Referral inspection · Safety discipline

On , OSHA opened a referral safety inspection of RARITAN PHARMACEUTICALS in 8 JOANNA COURT, EAST BRUNSWICK, NJ 08816 (NAICS 325412). OSHA activity number 339859423.

What this inspection record means

OSHA opens inspections for many reasons: routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.

Watch Raritan Pharmaceuticals for free Get an email when a new federal OSHA severe-injury report for Raritan Pharmaceuticals is published. One employer, no account, unsubscribe in one click.
Site address
8 JOANNA COURT
City
EAST BRUNSWICK
State
NJ
ZIP
08816
Mailing
8 JOANNA COURT, EAST BRUNSWICK, NJ 08816
Inspection type
Referral (C)
Scope
Partial (B)
Discipline
Safety
Advance notice
No
Union status
Non-union (B)
Opened
Closing conference
Case closed
Last modified
Data loaded
NAICS code
325412
Employees
160
Ownership type
Private (A)

3 citations on file for this inspection.

1910.147 C07 I

Serious Gravity 5 1 instance 1 exposed
Issued
Oct 30, 2014
Penalty
Initial $3,825 · Current $2,486 Reduced
29 CFR 1910.147(c)(7)(i): The employer did not provide adequate training to ensure that the purpose and function of the energy control program was understood by employees:    a- Raritan Pharmaceuticals, East Brunswick, NJ - Employees required to assist the machine operator in the cleaning process of machinery, such as but not limited to the tablet press, were not adequately trained in the energy control procedure program.        Condition noted on or about 7/16/14.
Recent events (3)
  • · R (S) $2486.25
  • · C (S) $3825
  • · Z (S) $3825

1904.29 B03

Other-than-serious 1 instance 1 exposed
Issued
Oct 30, 2014
Abate by
Nov 12, 2014
Penalty
Initial $765 · Current $497 Reduced
29 CFR 1904.29(b)(3): Each recordable injury or illness was not entered on the OSHA 300 Log within seven (7) calendar days of receiving information that a recordable injury or illness has occurred:    a- Raritan Pharmaceuticals - A recordable injury, which occurred on 7/16/14, was not entered on the 2014 OSHA 300 log within 7 calendar days.    Condition noted on or about 8/25/14.
Recent events (3)
  • · R (O) $497.25
  • · C (O) $765
  • · Z (O) $765

1910.1200 H03 IV

Other-than-serious 1 instance 200 exposed
Issued
Oct 30, 2014
Abate by
Dec 18, 2014
Penalty
Initial $0 · Current $0
29 CFR 1910.1200(h)(3)(iv):   The details of the hazard communication program developed by the employer, did not include an explanation of the  safety data sheet, including the order of information and how employee could obtain and use the appropriate hazard information:  a- Raritan Pharmaceuticals, East Brunswick, NJ - Employee training on the new label elements and the safety data sheet(SDS) format for the revised hazard communication standard (HCS) was not conducted.  Condition noted on or about 8/25/14.
Recent events (3)
  • · R (O) $0
  • · C (O) $0
  • · Z (O) $0

View Raritan Pharmaceuticals's full OSHA safety record →

This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). OSHA publishes its own view of this case as inspection number 339859423.

Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.